Integrated Diagnostics announced this week that it has appointed Kenneth Fang chief medical officer and vice president of translational research and clinical development. He will lead the company's efforts for early detection of diseases including lung cancer and Alzheimer's.
Previously Fang was senior director for clinical development at XDx and a faculty member at the University of California at San Francisco. He also co-founded Modus BioMedicine.
Proteome Sciences announced that Alf Lindberg has resigned from its board of directors.
Catherine Derasp this month joined PharmaNet as vice president of clinical operations for the company's Phase I trials, overseeing management of its 350-bed clinical operations in Montreal and Quebec City, Canada.